drugset / Trial / NCT03685188

Oxycodone and Sufentanil for Analgesia in Hip Surgery

NCT03685188

Phase 4 Enrolling by invitation 570 enrolled West China Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

We design this randomized controlled trial to compare the safety and efficacy of Oxycodone and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse reactions and promoting patients' rehabilitation.

Timeline

Start
2018-12-01
Primary completion
2024-12-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 0.4 mg/ml Intravenous
Comparator Sufentanil Other / unclassified 2 ug/ml Intravenous

Indications

No indication recorded.